Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8365
Reference
Drug alert 01/2025
Name
Drug Alert Class 4 Drug Alert 01 2025 – Class 4 medicines defect information – caution in use – Bristol Laboratories Ltd – Rabeprazole Sodium 10mg gastro-resistant tablets
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Drugs
Safety
Risks
Pharmaceutical Industry
Medicines Recall
Description
Bristol Laboratories Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the above specified batches of Rabeprazole sodium 10 mg gastro-resistant tablets and Rabeprazole sodium 20 mg gastro-resistant tablets do not contain the most up to date safety information.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Contact Phone
Created
2025-01-09 08:44:00
Click to go back to homepage